Wednesday, November 12, 2003

OncoLink at CFS 2003

OncoLink's daily online reports from the Chemotherapy Foundation Symposium in New York City on November 12-14, 2003. For those users interested in obtaining CME for this program, please enter the CME portion of this course.

OncoLink at CFS 2003
Broadway, New York City

Adjuvant Multimodality with Gemcitabine versus 5-Fluorouracil in Pancreatic Cancer: Status of U.S. Intergroup Trial
Alimta and Oxaliplatin in Colorectal Cancer
Bevacizumab (Avastin) in Colorectal Cancer
Emerging Role of EGF (Epidermal Growth Factor) Receptor-Directed Therapy of Colon Cancer
Experience with decitabine in imatinib resistant CML
High dose imatinib (Gleevac) in CML
Mini Allo Transplants for Lymphoma/CLL
Modulating IL-2 for Non-Hodgkins' Lymphoma (NHL)
Patient-specific therapeutic vaccines for non-Hodgkin's lymphoma
PTK 787/ZK 222584: Clinical results with a novel angiogenesis inhibitor in colorectal cancer
Treatment of Cancer-Related Anemia

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More